|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 23, No 21 (July 20), 2005: pp. 4735-4741 © 2005 American Society of Clinical Oncology. DOI: 10.1200/JCO.2005.02.899 Pediatric Melanoma: Risk Factor and Survival Analysis of the Surveillance, Epidemiology and End Results DatabaseFrom the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore; Biostatistics Branch and Genetics Epidemiology Branch/Division of Cancer Epidemiology and Genetics and Pediatric Oncology Branch/Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD Address reprint requests to John J. Strouse, MD, Division of Pediatric Hematology, 720 Rutland Ave, Ross 1125, Baltimore, MD 21205; e-mail: jstrous1{at}jhmi.edu PURPOSE: To evaluate risk factors for the development of and factors influencing survival in pediatric melanoma. PATIENTS AND METHODS: We evaluated 1,255 children (age < 20 years) and 2,673 young adults (age 20 to 24 years) with melanoma in the 2001 National Cancer Institute (NCI) Surveillance, Epidemiology and End Results (SEER) database. We estimated exposure to UV radiation based on Environmental Protection Agency (EPA) measurements. RESULTS: The incidence of pediatric melanoma increased 46% (95% CI, 40 to 52) per year of age and 2.9% (95% CI, 2.1 to 3.6) per year from 1973 to 2001. Incidence rates were lower in black patients (95%; 95% CI, 98 to 90) compared with white patients and in male patients (39%; 95% CI 46 to 31) compared with females. Increased ambient UV radiation was associated with elevated risk (19% per kJ; 95% CI, 9 to 30). Children with melanoma had a 5-year melanoma-specific survival of 93.6% (95% CI, 91.9 to 94.9), which improved from 1973 to 2001. The hazard ratio of death from melanoma increased with male sex; older age; advanced disease; location of the primary other than extremities or torso; earlier year of diagnosis; and previous cancer. CONCLUSION: The incidence of melanoma in the United States is increasing rapidly in children. Risk factors for pediatric melanoma include being white, being female, increasing age, and environmental UV radiation. Survival is decreased for children and adolescents with unfavorable prognostic factors (male sex, unfavorable site, and/or second primary or regional or distant metastasis). More effective therapeutic strategies are needed for these groups. Supported by a National Cancer Institute K12 Training Grant, 2K12CA001709-11 (J.J.S.). Presented at the 40th Annual Meeting of American Society of Clinical Oncology, New Orleans, LA, June 5-8, 2004. Authors' disclosures of potential conflicts of interest are found at the end of this article. This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|